Dr. Haytham Aljoudi, MD

Dr. Aljoudi practices at Zeiter Eye Medical Group, Inc. in Stockton, California.

Dr. Aljoudi's NPI, 1699969287, was assigned on August 28, 2007. Dr. Aljoudi graduated from University of Jordan Faculty of Medicine in 2001. Dr. Aljoudi holds California license C150276.

Dr. Aljoudi's primary practice is Zeiter Eye Medical Group, Inc., at 1801 E March Ln, Stockton, CA 95210 in San Joaquin County. The practice phone is (209) 951-1178.

Dr. Aljoudi's primary practice is Zeiter Eye Medical Group, Inc. in Stockton, California. Dr. Aljoudi is also affiliated with Dignity Health - St. Joseph's Medical Center. The medical group on file is Adventist Health Physicians Network. Dmand AI also links Dr. Aljoudi to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aljoudi practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Aljoudi's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Aljoudi is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Aljoudi's licenses on file in 5 states: California, New Mexico, West Virginia, New Jersey and Washington.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic hypertension and chronic skin ulcer among the conditions Dr. Aljoudi treats.

CMS data shows 5,270 Medicare services from Dr. Aljoudi across 39 procedure codes in 2024, for 1,742 Medicare patients. Medicare paid $337,254 for them.

CMS counts 1,742 Medicare patients who saw Dr. Aljoudi in 2024. The largest group is 65 to 74, with 622 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aljoudi's median patient age at 64, with 56% women.

In 2024, Dr. Aljoudi wrote 4,182 Medicare Part D claims for 709 patients. 74% of them were for generic drugs. CMS names the drug for 3,930 of them, across 40 drugs with 11 or more claims each, at $963,904 in total drug cost. In 2023, CMS named 2,647 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Aljoudi for performance year 2024, reported through an alternative payment model (APM). Dr. Aljoudi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 24 procedures of pacemaker insertion or repair by Dr. Aljoudi, more than 74% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Aljoudi in 2018. Dr. Aljoudi's most frequent co-authors are Alaa Gabi, MD and Nitin Kumar Puri, MD.

CMS Open Payments shows 599 general payments to Dr. Aljoudi from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 57% of the total. Medtronic, Inc. paid the most, $8,927.

Dr. Aljoudi graduated from University of Jordan Faculty of Medicine in 2001. Dr. Aljoudi is a member of ACC and ACP.

Dr. Aljoudi is in network with 18 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.